The Interaction of MS-325 with Human Serum Albumin and Its Effect on Proton Relaxation Rates
Top Cited Papers
- 27 February 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 124 (12) , 3152-3162
- https://doi.org/10.1021/ja017168k
Abstract
MS-325 is a novel blood pool contrast agent for magnetic resonance imaging currently undergoing clinical trials to assess blockage in arteries. MS-325 functions by binding to human serum albumin (HSA) in plasma. Binding to HSA serves to prolong plasma half-life, retain the agent in the blood pool, and increase the relaxation rate of water protons in plasma. Ultrafiltration studies with a 5 kDa molecular weight cutoff filter show that MS-325 binds to HSA with stepwise stoichiometric affinity constants (mM-1) of Ka1 = 11.0 ± 2.7, Ka2 = 0.84 ± 0.16, Ka3 = 0.26 ± 0.14, and Ka4 = 0.43 ± 0.24. Under the conditions 0.1 mM MS-325, 4.5% HSA, pH 7.4 (phosphate-buffered saline), and 37 °C, 88 ± 2% of MS-325 is bound to albumin. Fluorescent probe displacement studies show that MS-325 can displace dansyl sarcosine and dansyl-l-asparagine from HSA with inhibition constants (Ki) of 85 ± 3 μM and 1500 ± 850 μM, respectively; however, MS-325 is unable to displace warfarin. These results suggest that MS-325 binds primarily to site II on HSA. The relaxivity of MS-325 when bound to HSA is shown to be site dependent. The Eu(III) analogue of MS-325 is shown to contain one inner-sphere water molecule in the presence and in the absence of HSA. The synthesis of an MS-325 analogue, 5, containing no inner-sphere water molecules is described. Compound 5 is used to estimate the contribution to relaxivity from the outer-sphere water molecules surrounding MS-325. The high relaxivity of MS-325 bound to HSA is primarily because of a 60−100-fold increase in the rotational correlation time of the molecule upon binding (τR = 10.1 ± 2.6 ns bound vs 115 ps free). Analysis of the nuclear magnetic relaxation dispersion (T1 and T2) profiles also suggests a decrease in the electronic relaxation rate (1/T1e at 20 MHz = 2.0 × 108 s-1 bound vs 1.1 × 109 s-1 free) and an increase in the inner-sphere water residency time (τm = 170 ± 40 ns bound vs 69 ± 20 ns free).Keywords
This publication has 32 references indexed in Scilit:
- NOVEL PARAMAGNETIC MACROMOLECULAR COMPLEXES DERIVED FROM THE LINKAGE OF A MACROCYCLIC Gd(III) COMPLEX TO POLYAMINO ACIDS THROUGH A SQUARIC ACID MOIETYBioconjugate Chemistry, 1999
- Polymeric Conjugates of Gd3+−Diethylenetriaminepentaacetic Acid and Dextran. 2. Influence of Spacer Arm Length and Conjugate Molecular Mass on the Paramagnetic Properties and Some Biological ParametersBioconjugate Chemistry, 1998
- Towards MRI contrast agents of improved efficacy. NMR relaxometric investigations of the binding interaction to HSA of a novel heptadentate macrocyclic triphosphonate Gd(III)-complexJBIC Journal of Biological Inorganic Chemistry, 1997
- Polymeric Conjugates of Gd3+−Diethylenetriaminepentaacetic Acid and Dextran. 1. Synthesis, Characterization, and Paramagnetic PropertiesBioconjugate Chemistry, 1997
- Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1Journal of the American Chemical Society, 1996
- Paramagnetic Dextrans as Magnetic Resonance Blood Pool TracersInvestigative Radiology, 1994
- A double-sided radio jet from the compact Galactic Centre annihilator 1E1740.7–2942Nature, 1992
- Site-specific water proton relaxation enhancement of iron (III) chelates noncovalently bound to human serum albuminMagnetic Resonance in Medicine, 1991
- Equilibrium studies of lanthanide nitrate complexation in aqueous methanolInorganic Chemistry, 1990
- 1/T1 NMRD profiles of solutions of Mn2+ and Gd3+ protein‐chelate conjugatesMagnetic Resonance in Medicine, 1986